Sinn DH - Search Results

1

Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients.

Chon HY, Ahn SH, Kim YJ, Yoon JH, Lee JH, Sinn DH, Kim SU. Chon HY, et al. Among authors: sinn dh. Hepatol Int. 2021 Dec;15(6):1328-1336. doi: 10.1007/s12072-021-10262-y. Epub 2021 Nov 20. Hepatol Int. 2021. PMID: 34799838

2

Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus.

Sinn DH, Kim JH, Kim S, Son HJ, Kim JJ, Rhee JC, Rhee PL. Sinn DH, et al. Aliment Pharmacol Ther. 2008 Jun;27(12):1275-81. doi: 10.1111/j.1365-2036.2008.03659.x. Epub 2008 Feb 27. Aliment Pharmacol Ther. 2008. PMID: 18315581 Free article. Clinical Trial.

3

Disease progression and the risk factor analysis for chronic hepatitis C.

Sinn DH, Paik SW, Kang P, Kil JS, Park SU, Lee SY, Song SM, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC. Sinn DH, et al. Liver Int. 2008 Dec;28(10):1363-9. doi: 10.1111/j.1478-3231.2008.01860.x. Liver Int. 2008. PMID: 18710426

4

Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response.

Shin SR, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Shin SR, et al. Among authors: sinn dh. J Gastroenterol Hepatol. 2010 May;25(5):957-63. doi: 10.1111/j.1440-1746.2009.06176.x. J Gastroenterol Hepatol. 2010. PMID: 20546450

5

Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients.

Kim YJ, Cho HC, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Kim YJ, et al. Among authors: sinn dh. J Gastroenterol Hepatol. 2012 Feb;27(2):306-12. doi: 10.1111/j.1440-1746.2011.06852.x. J Gastroenterol Hepatol. 2012. PMID: 21777281

6

Ribavirin dose and treatment outcome of Korean patients with genotype 1 chronic hepatitis C.

Sinn DH, Kim J, Shin SR, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Sinn DH, et al. Hepatogastroenterology. 2012 Jan-Feb;59(113):1-6. doi: 10.5754/hge11387. Hepatogastroenterology. 2012. PMID: 21940368

7

Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance.

Kim YJ, Paik SW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC. Kim YJ, et al. Among authors: sinn dh. J Gastroenterol Hepatol. 2012 Sep;27(9):1454-60. doi: 10.1111/j.1440-1746.2011.07050.x. J Gastroenterol Hepatol. 2012. PMID: 22168753

8

Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study.

Sinn DH, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Dig Dis Sci. 2013 Mar;58(3):751-8. doi: 10.1007/s10620-012-2408-9. Epub 2012 Sep 30. Dig Dis Sci. 2013. PMID: 23053886

9

Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures.

Kim YJ, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Kim YJ, et al. Among authors: sinn dh. World J Gastroenterol. 2012 Dec 21;18(47):6996-7002. doi: 10.3748/wjg.v18.i47.6996. World J Gastroenterol. 2012. PMID: 23322999 Free PMC article. Clinical Trial.

10

Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.

Ahn JS, Jeon JR, Yoo HS, Park TK, Park CK, Sinn DH, Paik SW. Ahn JS, et al. Among authors: sinn dh. Clin Mol Hepatol. 2013 Jun;19(2):173-8. doi: 10.3350/cmh.2013.19.2.173. Epub 2013 Jun 27. Clin Mol Hepatol. 2013. PMID: 23837142 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters